Qube Research & Technologies (QRT)
ANGO icon

Qube Research & Technologies (QRT)’s AngioDynamics ANGO Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio ANGO Stock Details ANGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-38,813
Closed -$441K – 3437
2026
Q1 		$441K Sell
38,813
-190,483
-83% -$2.06M ﹤0.01% 2775
2025
Q4 		$2.94M Sell
229,296
-20,414
-8% -$252K ﹤0.01% 2064
2025
Q3 		$2.79M Sell
249,710
-43,486
-15% -$420K ﹤0.01% 2074
2025
Q2 		$2.91M Sell
293,196
-78,629
-21% -$770K ﹤0.01% 2013
2025
Q1 		$3.49M Buy
371,825
+324,269
+682% +$3.41M ﹤0.01% 1720
2024
Q4 		$436K Sell
47,556
-145,451
-75% -$1.07M ﹤0.01% 2541
2024
Q3 		$1.5M Buy
193,007
+181,565
+1,587% +$1.31M ﹤0.01% 1875
2024
Q2 		$69.2K Sell
11,442
-132,557
-92% -$818K ﹤0.01% 2671
2024
Q1 		$845K Buy
143,999
+64,081
+80% +$381K ﹤0.01% 2245
2023
Q4 		$627K Sell
79,918
-46,239
-37% -$321K ﹤0.01% 2166
2023
Q3 		$922K Buy
126,157
+46,830
+59% +$390K ﹤0.01% 1769
2023
Q2 		$827K Sell
79,327
-23,201
-23% -$223K ﹤0.01% 1377
2023
Q1 		$1.06M Buy
102,528
+10,876
+12% +$139K ﹤0.01% 1266
2022
Q4 		$1.26M Buy
+91,652
New +$1.28M 0.01% 1115
2022
Q2 		– Sell
-28,251
Closed -$609K – 2456
2022
Q1 		$609K Buy
28,251
+8,275
+41% +$188K 0.01% 1439
2021
Q4 		$551K Sell
19,976
-9,450
-32% -$261K ﹤0.01% 1514
2021
Q3 		$763K Buy
29,426
+20,475
+229% +$548K 0.01% 1008
2021
Q2 		$243K Buy
+8,951
New +$219K ﹤0.01% 1700
2020
Q1 		– Sell
-16,071
Closed -$257K – 1105
2019
Q4 		$257K Buy
+16,071
New +$245K 0.01% 1295

Other funds holding ANGO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $5.02B AUM 66.06% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
BH
Broadfin Holdings Melville, New York $23.7M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
WCM
Weber Capital Management San Francisco, California $118M AUM
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Qube Research & Technologies (QRT)'s ANGO Position: Q2 2026 in Review

Qube Research & Technologies (QRT) sold out of AngioDynamics (ANGO) in Q2 2026, closing a stake of 38,813 shares — an estimated $441K sold.

Qube Research & Technologies (QRT) first reported a position in ANGO in Q4 2019 and held it in 19 quarters. The position peaked at $3.49M in Q1 2025. 161 funds tracked by Wall St. Rank hold ANGO as of Q2 2026.

  • Qube Research & Technologies (QRT) reported no remaining AngioDynamics position as of Q2 2026 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 38,813 AngioDynamics shares in Q2 2026, an estimated $441K.
  • Qube Research & Technologies (QRT) first reported a position in AngioDynamics in Q4 2019 and held it in 19 quarters.
  • Qube Research & Technologies (QRT)'s AngioDynamics position peaked at $3.49M in Q1 2025.
  • 161 funds tracked by Wall St. Rank held AngioDynamics as of Q2 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.